ClinConnect ClinConnect Logo
Search / Trial NCT06036732

A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Sep 13, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Five Score Four Score Gcs Modified Rankin Score Neuro Icu

ClinConnect Summary

This clinical trial is looking at a new way to assess consciousness in patients who are recovering in the Intensive Care Unit (ICU) after serious brain surgeries or injuries. The main goal is to see how the new FIVE score relates to how long patients stay in the ICU. Researchers also want to understand how this score affects the overall time spent in the hospital, patients' recovery outcomes, and how it compares to other existing scoring systems.

To participate, individuals must be between 18 and 80 years old and have been treated in the Neurosurgical ICU for specific conditions, such as strokes or brain surgeries. However, those over 80, under 18, or with certain medical conditions (like psychiatric illnesses or ongoing substance abuse) won’t be eligible. If you or a family member qualifies, participating in the trial will involve monitoring and evaluation using the FIVE score, which could help improve care for future patients in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • between the ages of 18 and 80
  • who were monitored in the Neurosurgical Intensive Care Unit
  • had a history of ischemic or hemorrhagic stroke within the last 6 months
  • underwent infratentorial craniotomy
  • supratentorial craniotomy
  • endoscopic surgery
  • vascular surgery
  • epilepsy surgery
  • hydrocephalus surgery
  • neurovascular intervention
  • Exclusion Criteria:
  • patients over 80 years of age
  • under 18 years of age
  • patients who were sedated
  • patients who were administered neuromuscular blockers during intensive care follow-up
  • patients with diagnosed psychiatric illness
  • patients who were alcohol or drug addicts

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Istanbul, Fatih, Turkey

Patients applied

0 patients applied

Trial Officials

Ozlem Korkmaz Dilmen, MD

Study Chair

Istanbul University - Cerrahpasa

Yusuf Tunali, MD

Study Director

Istanbul University - Cerrahpasa

Fatma Eren Akcil, MD

Study Director

Istanbul University - Cerrahpasa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported